Associated Papers
Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.
Boot A et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
35058360 (PubMed )
Supplement: pnas.2114024119.sd08.xlsx › Dataset.S8
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K et al.
Oncoimmunology, 2013
24501689 (PubMed )
Supplement: onci-2-e27090-s01.pdf
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S et al.
Nature, 2009
Select a paper to view details